Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Furthermore, PARP-1 mutant overexpression in a pancreatic cancer cell line (MIA PaCa-2) increased sensitivity to platinum-based anticancer agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Furthermore, PARP-1 mutant overexpression in a pancreatic cancer cell line (MIA PaCa-2) increased sensitivity to platinum-based anticancer agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Furthermore, PARP-1 mutant overexpression in a pancreatic cancer cell line (MIA PaCa-2) increased sensitivity to platinum-based anticancer agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP225210.RAXfX5zDdkbpqU4qrZuw1B1PWRLTSBJhlp757acvMSmfk130_assertion description "[Furthermore, PARP-1 mutant overexpression in a pancreatic cancer cell line (MIA PaCa-2) increased sensitivity to platinum-based anticancer agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP225210.RAXfX5zDdkbpqU4qrZuw1B1PWRLTSBJhlp757acvMSmfk130_provenance.
• NP792397.RAWMacGo6vEmu_oKpLRk_YuRnpcdiB6SUP_jE4INb18fk130_assertion description "[Furthermore, PARP-1 mutant overexpression in a pancreatic cancer cell line (MIA PaCa-2) increased sensitivity to platinum-based anticancer agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP792397.RAWMacGo6vEmu_oKpLRk_YuRnpcdiB6SUP_jE4INb18fk130_provenance.
• assertion description "[Furthermore, PARP-1 mutant overexpression in a pancreatic cancer cell line (MIA PaCa-2) increased sensitivity to platinum-based anticancer agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Furthermore, PARP-1 mutant overexpression in a pancreatic cancer cell line (MIA PaCa-2) increased sensitivity to platinum-based anticancer agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Furthermore, PARP-1 mutant overexpression in a pancreatic cancer cell line (MIA PaCa-2) increased sensitivity to platinum-based anticancer agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Furthermore, PARP-1 mutant overexpression in a pancreatic cancer cell line (MIA PaCa-2) increased sensitivity to platinum-based anticancer agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1124866.RATZELRENyWNNBtZhFRtpo_kgeaajHpx0pYvYKesXIPcQ130_assertion description "[Furthermore, PARP-1 mutant overexpression in a pancreatic cancer cell line (MIA PaCa-2) increased sensitivity to platinum-based anticancer agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1124866.RATZELRENyWNNBtZhFRtpo_kgeaajHpx0pYvYKesXIPcQ130_provenance.
• NP1124868.RAZxmTs---QWx68HdzqMeMngDBRlhc2HdZBecVfU4Fcas130_assertion description "[Furthermore, PARP-1 mutant overexpression in a pancreatic cancer cell line (MIA PaCa-2) increased sensitivity to platinum-based anticancer agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1124868.RAZxmTs---QWx68HdzqMeMngDBRlhc2HdZBecVfU4Fcas130_provenance.
• NP1124869.RAd_8nCiFa2CENN-RegV96_8AwCdksNz5N3_2u0jauMbg130_assertion description "[Furthermore, PARP-1 mutant overexpression in a pancreatic cancer cell line (MIA PaCa-2) increased sensitivity to platinum-based anticancer agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1124869.RAd_8nCiFa2CENN-RegV96_8AwCdksNz5N3_2u0jauMbg130_provenance.
• NP1124870.RAb90UZE_SxVJtmJ85YQf_wSrHJvxmQjGvtRTMGM8CVt4130_assertion description "[Furthermore, PARP-1 mutant overexpression in a pancreatic cancer cell line (MIA PaCa-2) increased sensitivity to platinum-based anticancer agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1124870.RAb90UZE_SxVJtmJ85YQf_wSrHJvxmQjGvtRTMGM8CVt4130_provenance.
• NP880645.RApGh2Yr-H6MMhp_Aeu0uw0GILFhzryW-IgISSs3p4XrQ130_assertion description "[Furthermore, PARP-1 mutant overexpression in a pancreatic cancer cell line (MIA PaCa-2) increased sensitivity to platinum-based anticancer agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP880645.RApGh2Yr-H6MMhp_Aeu0uw0GILFhzryW-IgISSs3p4XrQ130_provenance.
• NP1124865.RAqm4z1BsrjP8ekbSrPx6JOA2G0N-pVjUTxEej8EiDiis130_assertion description "[Furthermore, PARP-1 mutant overexpression in a pancreatic cancer cell line (MIA PaCa-2) increased sensitivity to platinum-based anticancer agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1124865.RAqm4z1BsrjP8ekbSrPx6JOA2G0N-pVjUTxEej8EiDiis130_provenance.
• NP1124867.RArbFb3L0dXvt4lmVBxLp8r5MYyM9FVbNIuOWa4QC9RBY130_assertion description "[Furthermore, PARP-1 mutant overexpression in a pancreatic cancer cell line (MIA PaCa-2) increased sensitivity to platinum-based anticancer agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1124867.RArbFb3L0dXvt4lmVBxLp8r5MYyM9FVbNIuOWa4QC9RBY130_provenance.
• NP225267.RAyQo4hOz4zRUF0eXiEg05H5lwkoqnOp5iVeOgfYoj4EQ130_assertion description "[Furthermore, PARP-1 mutant overexpression in a pancreatic cancer cell line (MIA PaCa-2) increased sensitivity to platinum-based anticancer agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP225267.RAyQo4hOz4zRUF0eXiEg05H5lwkoqnOp5iVeOgfYoj4EQ130_provenance.
• NP792418.RANJO2yneHA-PvlHt-oojWF7zdgdA1-tnGl41-MjvcDBQ130_assertion description "[Furthermore, PARP-1 mutant overexpression in a pancreatic cancer cell line (MIA PaCa-2) increased sensitivity to platinum-based anticancer agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP792418.RANJO2yneHA-PvlHt-oojWF7zdgdA1-tnGl41-MjvcDBQ130_provenance.
• NP880652.RAIi8b6gz0FkHhCOmTEzzy2uCkeu1FM3EI3KniNrIPTzo130_assertion description "[Furthermore, PARP-1 mutant overexpression in a pancreatic cancer cell line (MIA PaCa-2) increased sensitivity to platinum-based anticancer agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP880652.RAIi8b6gz0FkHhCOmTEzzy2uCkeu1FM3EI3KniNrIPTzo130_provenance.